Notice ID: c69758f097094d7a8b2eea93c9cf6ca8Special NoticeArchived
Gendx Tissue Typing
Archived on August 21, 2025. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 1:00 PM CDT
- Posted
- July 31, 2025
- Notice type
- Special Notice
- Set-aside
- No Set aside used
Notice details
- Office
- NETWORK CONTRACT OFFICE 23 (36C263)
- Place of performance
- Iowa City, 52246
- Last updated
- Nov 10, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 36C26325Q1006
- Notice ID
- c69758f097094d7a8b2eea93c9cf6ca8
Description
This is a Notice of Intent published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This Notice of Intent is for a proposed award of a sole source firm fixed price contract to the following contractor in support of needed Next Generation Sequencing (NGS) kits to support the Iowa City VA Health Care System. GENDX PRODUCTS LLC SAM UEI: JFZKARM2NL52 15222 Avenue Of Science STE A San Diego, California 92128-3422, United States This is done under authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1: Only one source and no other supplies or services will satisfy agency requirements. This is not a request for competitive quotes. Market research revealed that GENDX PRODUCTS LLC is the sole company that is able to provide support for the needed Next Generation Sequencing (NGS) kits to support the Iowa City VA Health Care System. The North American Industry Classification System (NAICS) code for this service is 325413 (In Vitro Diagnostic Substance Manufacturing) and the Product Service Code (PSC) is 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets). While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy the requirement, including documentation from the proprietary rights holder GENDX PRODUCTS LLC that such contractor could provide this service as an authorized reseller, authorized dealer or third party. All responsible sources may submit a capability statement, which shall be considered by the agency by e-mailing such statement and supporting documentation to Emanuel Nevarez, Contracting Specialist emanuel.nevarez@va.gov. No phone calls please. Please indicate 36C26325Q1006 BD GENDX Tissue Typing in subject line of e-mail. Such documentation will be reviewed solely for the purpose of determining whether or not to conduct the procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government under authorities cited above. See Attached Statement of Work (SOW)
Award Overview
Possible prior contract
Inferred, not confirmedInferred, not confirmed. Matched by agency, NAICS, place of performance and end-date proximity. This is a candidate, not the contractor of record.
Dollar amounts are not shown for inferred matches because the link is heuristic. Open the award below to check it.
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
GenDx Reagents SOW FY26.docx
22 KBAdded in Special Notice version 3Posted
Lifecycle
- 3Version 3Special NoticeArchivedCurrent
Gendx Tissue Typing
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36C26325Q1006
Archive Date
Aug 21, 2025